SLC25A1 (Solute Carrier Family 25 Member 1), also known as the mitochondrial citrate carrier (CIC), is a nuclear-encoded mitochondrial transporter protein that plays a critical role in cellular metabolism. This gene encodes a carrier protein that transports citrate from the mitochondrion to the cytosol, where it provides acetyl-CoA for fatty acid synthesis and lipid metabolism. In the brain, SLC25A1 plays a vital role in metabolic regulation and has been implicated in various neurological conditions including Alzheimer's disease, Parkinson's disease, and certain forms of dystonia. The citrate carrier is essential for maintaining cellular energy metabolism and biosynthetic processes, particularly in highly metabolic tissues like the brain. Dysregulation of SLC25A1 may contribute to metabolic disorders and neurodegeneration through effects on mitochondrial function and lipid homeostasis. [@citrate_carrier]
SLC25A1 (Solute Carrier Family 25 Member 1), also known as the mitochondrial citrate carrier (CIC), is a nuclear-encoded mitochondrial transporter protein that plays a critical role in cellular metabolism. This gene encodes a carrier protein that transports citrate from the mitochondrion to the cytosol, where it provides acetyl-CoA for fatty acid synthesis and lipid metabolism. In the brain, SLC25A1 plays a vital role in metabolic regulation and has been implicated in various neurological conditions including Alzheimer's disease, Parkinson's disease, and certain forms of dystonia. The citrate carrier is essential for maintaining cellular energy metabolism and biosynthetic processes, particularly in highly metabolic tissues like the brain. Dysregulation of SLC25A1 may contribute to metabolic disorders and neurodegeneration through effects on mitochondrial function and lipid homeostasis. [@citrate_carrier]
<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Solute Carrier Family 25 Member 1</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>SLC25A1</td></tr>
<tr><td><strong>Full Name</strong></td><td>Solute carrier family 25 member 1 (Mitochondrial citrate carrier)</td></tr>
<tr><td><strong>Chromosome</strong></td><td>22q11.21</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[84069](https://www.ncbi.nlm.nih.gov/gene/84069)</td></tr>
<tr><td><strong>OMIM</strong></td><td>616658</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000100100</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BRA2](https://www.uniprot.org/uniprot/Q9BRA2)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, Mitochondrial Disorders, Dystonia</td></tr>
</table>
</div>
The SLC25A1 gene is located on chromosome 22q11.21, a region susceptible to microdeletions associated with DiGeorge syndrome. The gene spans approximately 4.5 kb and consists of 6 exons encoding a 311-amino acid protein. The promoter region contains response elements for several transcription factors including PPARα and SREBP, linking citrate transport to metabolic status. The genomic region is evolutionarily conserved, reflecting the fundamental importance of mitochondrial citrate transport in cellular metabolism. [@mitochondrial_carriers]
SLC25A1 belongs to the mitochondrial carrier family (MCF), a group of transporters that shuttle metabolites across the inner mitochondrial membrane:
The protein forms a homodimer or higher-order oligomer to function as a transport channel. Each monomer can operate independently, allowing for flexible regulation of transport activity.
SLC25A1 mediates the exchange of citrate with other dicarboxylates across the inner mitochondrial membrane:
Substrate Specificity
SLC25A1 serves as a crucial link between mitochondrial and cytosolic metabolism:
origin/main
Fatty Acid Synthesis
The brain has unique metabolic requirements that involve SLC25A1:
Neuronal Energy Metabolism
SLC25A1 is widely expressed with highest levels in metabolically active tissues:
High Expression
SLC25A1 expression is regulated at multiple levels:
Transcriptional Controls
SLC25A1 is implicated in Alzheimer's disease pathogenesis through several mechanisms:
Metabolic Dysfunction
SLC25A1 relevance to Parkinson's disease:
Mitochondrial Involvement
Primary SLC25A1 deficiency causes rare metabolic disorders:
SLC25A1 Deficiency Syndrome
SLC25A1 mutations are associated with certain forms of dystonia:
Genetic Evidence
Targeting Mitochondrial Function
Nutritional Approaches
Gene Therapy
| Disease | Association | Mechanism |
|---------|-------------|-----------|
| Alzheimer's Disease | Risk factor | Mitochondrial dysfunction, metabolic deficits, lipid dysregulation |
| Parkinson's Disease | Risk factor | Impaired mitochondrial metabolism, dopaminergic vulnerability |
| Mitochondrial Disorders | Direct cause | Primary SLC25A1 deficiency |
| Dystonia | Direct cause | Basal ganglia metabolic defects |
| Metabolic Syndrome | Risk factor | Impaired citrate transport, lipid abnormalities |